Obesogens, stem cells and the developmental programming of obesity

International Journal of Andrology

Volumn 35, Issue 3, 2012, Pages 437-448

  Janesick, A ^a   Blumberg, B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Development; Endocrine disrupters; Environmental factors; Epigenetics; Fish < animal models; Hormone receptors; Mouse < animal models; Obesity; Phthalates; Sex hormones

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; ATYPICAL ANTIPSYCHOTIC AGENT; CORTICOSTERONE; ENDOCRINE DISRUPTOR; ENVIRONMENTAL CHEMICAL; ESTROGEN; GLITAZONE DERIVATIVE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; OBESOGEN; OLANZAPINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; SEROTONIN UPTAKE INHIBITOR; SEX HORMONE; STEROID RECEPTOR; TRIBUTYLTIN; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; CELL PROLIFERATION; CORTICOSTEROID METABOLISM; DISEASE COURSE; DNA METHYLATION; ENVIRONMENTAL EXPOSURE; EPIGENETICS; GENE EXPRESSION; HUMAN; HYPERCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MATERNAL STRESS; MESENCHYMAL STEM CELL; METABOLISM; OBESITY; PREGNANCY; PRIORITY JOURNAL; REVIEW; STEM CELL; WEIGHT CONTROL; WEIGHT GAIN;

ADIPOGENESIS; ENDOCRINE DISRUPTORS; ENVIRONMENTAL EXPOSURE; EPIGENESIS, GENETIC; GLUCOCORTICOIDS; HUMANS; OBESITY; PPAR GAMMA; RECEPTORS, STEROID; STEM CELLS; TRIALKYLTIN COMPOUNDS;

EID: 84861454964     PISSN: 01056263     EISSN: 13652605     Source Type: Journal    
DOI: 10.1111/j.1365-2605.2012.01247.x     Document Type: Review

References (141)

1. Al Mamun A, Lawlor DA, Alati R, O'Callaghan MJ, Williams GM & Najman JM. (2006) Does maternal smoking during pregnancy have a direct effect on future offspring obesity? Evidence from a prospective birth cohort study. Am J Epidemiol 164, 317-325.
2. Anway MD, Cupp AS, Uzumcu M & Skinner MK. (2005) Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 308, 1466-1469.
3. Atanasov AG, Tam S, Rocken JM, Baker ME & Odermatt A. (2003) Inhibition of 11 beta-hydroxysteroid dehydrogenase type 2 by dithiocarbamates. Biochem Biophys Res Commun 308, 257-262.
4. Atanasov AG, Nashev LG, Tam S, Baker ME & Odermatt A. (2005) Organotins disrupt the 11beta-hydroxysteroid dehydrogenase type 2-dependent local inactivation of glucocorticoids. Environ Health Perspect 113, 1600-1606.
5. Barker DJ & Osmond C. (1986) Infant mortality, childhood nutrition, and ischaemic heart disease in england and wales. Lancet 1, 1077-1081.
6. Barker DJ & Osmond C. (1988) Low birth weight and hypertension. BMJ 297, 134-135.
7. Barker DJ, Osmond C, Golding J, Kuh D & Wadsworth ME. (1989) Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 298, 564-567.
8. Berken GH, Weinstein DO & Stern WC. (1984) Weight gain. A side-effect of tricyclic antidepressants. J Affect Disord 7, 133-138.
9. Bernal AJ & Jirtle RL. (2010) Epigenomic disruption: the effects of early developmental exposures. Birth Defects Res A Clin Mol Teratol 88, 938-944.
10. Bjorntorp P. (1991) Adipose tissue distribution and function. Int J Obes 15(Suppl. 2), 67-81.
11. Bjorntorp P. (1997) Neuroendocrine factors in obesity. J Endocrinol 155, 193-195.
12. Björntorp P. (1993) Visceral obesity: a "Civilization syndrome". Obes Res 1, 206-222.
13. Bjorntorp P & Rosmond R. (2000) Obesity and cortisol. Nutrition 16, 924-936.
14. Blaber SJM. (1970) The occurrence of a penis-like outgrowth behind the right tentacle in spent females of nucella lapillus. Proc Malacolog Soc Lon 39, 231-233.
15. Blumberg B. (2011) Obesogens, stem cells and the maternal programming of obesity. J Develop Orig Health Dis 2, 3-8.
16. Bujalska IJ, Kumar S, Hewison M & Stewart PM. (1999) Differentiation of adipose stromal cells: the roles of glucocorticoids and 11beta-hydroxysteroid dehydrogenase. Endocrinology 140, 3188-3196.
17. Burdge GC & Lillycrop KA. (2010a) Bridging the gap between epigenetics research and nutritional public health interventions. Genome Med 2, 80.
18. Burdge GC & Lillycrop KA. (2010b) Nutrition, epigenetics, and developmental plasticity: implications for understanding human disease. Annu Rev Nutr 30, 315-339.
19. Butte NF, Christiansen E & Sorensen TI. (2007) Energy imbalance underlying the development of childhood obesity. Obesity (Silver Spring) 15, 3056-3066.
20. Cagampang F, Anthony F & Hanson M. (2007) P2-14 developmental exposure to bisphenol-a leads to obesity and cardiovascular dysfunction in adult mouse offspring. Early Hum Dev 83, S132-S133.
21. Carwile JL & Michels KB. (2011) Urinary bisphenol a and obesity: Nhanes 2003-2006. Environ Res 111, 825-830.
22. Casals-Casas C & Desvergne B. (2011) Endocrine disruptors: from endocrine to metabolic disruption. Annu Rev Physiol 73, 135-162.
23. Casals-Casas C, Feige JN & Desvergne B. (2008) Interference of pollutants with ppars: endocrine disruption meets metabolism. Int J Obes (Lond) 32(Suppl. 6), S53-S61.
24. Chalew S, Nagel H & Shore S. (1995) The hypothalamic-pituitary-adrenal axis in obesity. Obes Res 3, 371-382.
25. Cooke PS, Heine PA, Taylor JA & Lubahn DB. (2001) The role of estrogen and estrogen receptor-alpha in male adipose tissue. Mol Cell Endocrinol 178, 147-154.
26. Desvergne B, Feige JN & Casals-Casas C. (2009) Ppar-mediated activity of phthalates: a link to the obesity epidemic? Mol Cell Endocrinol 304, 43-48.
27. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, Zoeller RT & Gore AC. (2009) Endocrine-disrupting chemicals: an endocrine society scientific statement. Endocr Rev 30, 293-342.
28. Dix DJ, Houck KA, Martin MT, Richard AM, Setzer RW & Kavlock RJ. (2007) The toxcast program for prioritizing toxicity testing of environmental chemicals. Toxicol Sci 95, 5-12.
29. Edwards CR, Benediktsson R, Lindsay RS & Seckl JR. (1993) Dysfunction of placental glucocorticoid barrier: link between fetal environment and adult hypertension? Lancet 341, 355-357.
30. Entringer S, Wust S, Kumsta R, Layes IM, Nelson EL, Hellhammer DH & Wadhwa PD. (2008) Prenatal psychosocial stress exposure is associated with insulin resistance in young adults. Am J Obstet Gynecol 199, 498 e491-497.
31. Entringer S, Kumsta R, Hellhammer DH, Wadhwa PD & Wust S. (2009) Prenatal exposure to maternal psychosocial stress and hpa axis regulation in young adults. Horm Behav 55, 292-298.
32. Entringer S, Buss C & Wadhwa PD. (2010) Prenatal stress and developmental programming of human health and disease risk: concepts and integration of empirical findings. Curr Opin Endocrinol Diabetes Obes 17, 507-516.
33. Eskenazi B, Fenster L, Castorina R, Marks AR, Sjodin A, Rosas LG, Holland N, Guerra AG, Lopez-Carrillo L & Bradman A. (2011) A comparison of pbde serum concentrations in mexican and mexican-american children living in california. Environ Health Perspect 119, 1442-1448.
34. Evans RM, Barish GD & Wang YX. (2004) Ppars and the complex journey to obesity. Nat Med 10, 355-361.
35. Fava M. (2000) Weight gain and antidepressants. J Clin Psychiatry 61(Suppl. 11), 37-41.
36. Feige JN, Gelman L, Rossi D, Zoete V, Metivier R, Tudor C et al. (2007) The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis. J Biol Chem 282, 19152-19166.
37. Fernandez-Real JM, Pugeat M, Grasa M, Broch M, Vendrell J, Brun J & Ricart W. (2002) Serum corticosteroid-binding globulin concentration and insulin resistance syndrome: a population study. J Clin Endocrinol Metab 87, 4686-4690.
38. Flegal KM, Carroll MD, Ogden CL & Curtin LR. (2010) Prevalence and trends in obesity among us adults, 1999-2008. JAMA 303, 235-241.
39. Freedland ES. (2004) Role of a critical visceral adipose tissue threshold (cvatt) in metabolic syndrome: implications for controlling dietary carbohydrates: a review. Nutr Metab (Lond) 1, 12.
40. Gibbs P & Bryan G. (1986) Reproductive failure in populations of the dog-whelk, nucella lapillus, caused by imposex induced by tributyltin from antifouling paints. J Mar Biol Assoc UK 66, 767-777.
41. Gluckman PD & Hanson MA. (2004) Living with the past: evolution, development, and patterns of disease. Science 305, 1733-1736.
42. Gluckman PD, Hanson MA, Beedle AS & Raubenheimer D. (2008) Fetal and neonatal pathways to obesity. Front Horm Res 36, 61-72.
43. Godfrey KM, Lillycrop KA, Burdge GC, Gluckman PD & Hanson MA. (2007) Epigenetic mechanisms and the mismatch concept of the developmental origins of health and disease. Pediatr Res 61, 5R-10R.
44. Godfrey KM, Sheppard A, Gluckman PD, Lillycrop KA, Burdge GC, McLean C et al. (2011) Epigenetic gene promoter methylation at birth is associated with child's later adiposity. Diabetes 60, 1528-1534.
45. Grun F. (2010) Obesogens. Curr Opin Endocrinol Diabetes Obes 17, 453-459.
46. Grun F & Blumberg B. (2009a) Endocrine disrupters as obesogens. Mol Cell Endocrinol 304, 19-29.
47. Grun F & Blumberg B. (2009b) Minireview: the case for obesogens. Mol Endocrinol 23, 1127-1134.
48. Grun F, Watanabe H, Zamanian Z, Maeda L, Arima K, Cubacha R, Gardiner DM, Kanno J, Iguchi T & Blumberg B. (2006) Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Mol Endocrinol 20, 2141-2155.
49. Gumy C, Chandsawangbhuwana C, Dzyakanchuk AA, Kratschmar DV, Baker ME & Odermatt A. (2008) Dibutyltin disrupts glucocorticoid receptor function and impairs glucocorticoid-induced suppression of cytokine production. PLoS ONE 3, e3545.
50. Hanson MA & Gluckman PD. (2008) Developmental origins of health and disease: new insights. Basic Clin Pharmacol Toxicol 102, 90-93.
51. Hanson M, Godfrey KM, Lillycrop KA, Burdge GC & Gluckman PD. (2011) Developmental plasticity and developmental origins of non-communicable disease: theoretical considerations and epigenetic mechanisms. Prog Biophys Mol Biol 106, 272-280.
52. Harley KG, Chevrier J, Schall RA, Sjodin A, Bradman A & Eskenazi B. (2011) Association of prenatal exposure to polybrominated diphenyl ethers and infant birth weight. Am J Epidemiol 174, 885-892.
53. Hauner H, Entenmann G, Wabitsch M, Gaillard D, Ailhaud G, Negrel R & Pfeiffer EF. (1989) Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J Clin Invest 84, 1663-1670.
54. Heindel JJ. (2011) The obesogen hypothesis of obesity: overview and human evidence. In: Obesity Before Birth, Vol. 30. (ed. RH Lustig ), pp. 355-366. Springer, US.
55. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB & Cooke PS. (2000) Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci U S A 97, 12729-12734.
56. Hoch M. (2001) Organotin compounds in the environment - an overview. Appl Geochem 16, 719-743.
57. Hochberg Z, Feil R, Constancia M, Fraga M, Junien C, Carel JC et al. (2011) Child health, developmental plasticity, and epigenetic programming. Endocr Rev 32, 159-224.
58. Hurst CH & Waxman DJ. (2003) Activation of pparalpha and ppargamma by environmental phthalate monoesters. Toxicol Sci 74, 297-308.
59. Ibrahim MM. (2010) Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev 11, 11-18.
60. Jackson AA, Burdge GC & Lillycrop KA. (2010) Diet, nutrition and modulation of genomic expression in fetal origins of adult disease. World Rev Nutr Diet 101, 56-72.
61. Janesick A & Blumberg B. (2011a) Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity. Birth Defects Res C Embryo Today 93, 34-50.
62. Janesick A & Blumberg B. (2011b) Minireview: Ppargamma as the target of obesogens. J Steroid Biochem Mol Biol 127, 4-8.
63. Janesick A & Blumberg B. (2011c) The role of environmental obesogens in the obesity epidemic. in: Obesity Before Birth, Vol. 30. (ed. RH Lustig ), pp. 383-399. Springer, US.
64. Jones ME, Thorburn AW, Britt KL, Hewitt KN, Wreford NG, Proietto J et al. (2000) Aromatase-deficient (arko) mice have a phenotype of increased adiposity. Proc Natl Acad Sci U S A 97, 12735-12740.
65. Joyner JM, Hutley LJ, Bachmann AW, Torpy DJ & Prins JB. (2003) Greater replication and differentiation of preadipocytes in inherited corticosteroid-binding globulin deficiency. Am J Physiol Endocrinol Metab 284, E1049-E1054.
66. Kanayama T, Kobayashi N, Mamiya S, Nakanishi T & Nishikawa J. (2005) Organotin compounds promote adipocyte differentiation as agonists of the peroxisome proliferator-activated receptor gamma/retinoid x receptor pathway. Mol Pharmacol 67, 766-774.
67. Kannan K, Takahashi S, Fujiwara N, Mizukawa H & Tanabe S. (2010) Organotin compounds, including butyltins and octyltins, in house dust from albany, New York, USA. Arch Environ Contam Toxicol 58, 901-907.
68. Karmaus W, Osuch JR, Eneli I, Mudd LM, Zhang J, Mikucki D, Haan P & Davis S. (2009) Maternal levels of dichlorodiphenyl-dichloroethylene (dde) may increase weight and body mass index in adult female offspring. Occup Environ Med 66, 143-149.
69. Kelce WR, Stone CR, Laws SC, Gray LE, Kemppainen JA & Wilson EM. (1995) Persistent ddt metabolite p, p'-dde is a potent androgen receptor antagonist. Nature 375, 581-585.
70. Kim HK, Nelson-Dooley C, Della-Fera MA, Yang JY, Zhang W, Duan J, Hartzell DL, Hamrick MW & Baile CA. (2006) Genistein decreases food intake, body weight, and fat pad weight and causes adipose tissue apoptosis in ovariectomized female mice. J Nutr 136, 409-414.
71. Kirchner S, Kieu T, Chow C, Casey S & Blumberg B. (2010) Prenatal exposure to the environmental obesogen tributyltin predisposes multipotent stem cells to become adipocytes. Mol Endocrinol 24, 526-539.
72. Knudsen TB, Houck KA, Sipes NS, Singh AV, Judson RS, Martin MT et al. (2011) Activity profiles of 309 toxcast chemicals evaluated across 292 biochemical targets. Toxicology 282, 1-15.
73. Kupfer D & Bulger WH. (1976) Studies on the mechanism of estrogenic actions of o, p'ddt: interactions with the estrogen receptor. Pesticide Biochem Physiol 6, 561-570.
74. La Merrill M & Birnbaum LS. (2011) Childhood obesity and environmental chemicals. Mt Sinai J Med 78, 22-48.
75. Larsen TM, Toubro S & Astrup A. (2003) Ppargamma agonists in the treatment of type ii diabetes: is increased fatness commensurate with long-term efficacy? Int J Obes Relat Metab Disord 27, 147-161.
76. Laudenslager ML, Wilkinson CW, Carlisle HJ & Hammel HT. (1980) Energy balance in ovariectomized rats with and without estrogen replacement. Am J Physiol 238, R400-R405.
77. Lee G, Elwood F, McNally J, Weiszmann J, Lindstrom M, Amaral K et al. (2002) T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities. J Biol Chem 277, 19649-19657.
78. Lee DH, Steffes MW, Sjodin A, Jones RS, Needham LL & Jacobs DR Jr. (2010) Low dose of some persistent organic pollutants predicts type 2 diabetes: a nested case-control study. Environ Health Perspect 118, 1235-1242.
79. Lee DH, Lind PM, Jacobs DR Jr, Salihovic S, van Bavel B & Lind L. (2011a) Polychlorinated biphenyls and organochlorine pesticides in plasma predict development of type 2 diabetes in the elderly: the prospective investigation of the vasculature in uppsala seniors (pivus) study. Diabetes Care 34, 1778-1784.
80. Lee DH, Steffes MW, Sjodin A, Jones RS, Needham LL & Jacobs DR Jr. (2011b) Low dose organochlorine pesticides and polychlorinated biphenyls predict obesity, dyslipidemia, and insulin resistance among people free of diabetes. PLoS ONE 6, e15977.
81. Lee DH, Lind L, Jacobs DR Jr, Salihovic S, van Bavel B & Lind PM. (2012) Associations of persistent organic pollutants with abdominal obesity in the elderly: the prospective investigation of the vasculature in uppsala seniors (pivus) study. Environ Int 40, 170-178.
82. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM & Kliewer SA. (1995) An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (ppar gamma). J Biol Chem 270, 12953-12956.
83. Li S, Washburn KA, Moore R, Uno T, Teng C, Newbold RR, McLachlan JA & Negishi M. (1997) Developmental exposure to diethylstilbestrol elicits demethylation of estrogen-responsive lactoferrin gene in mouse uterus. Cancer Res 57, 4356-4359.
84. Li X, Ycaza J & Blumberg B. (2011) The environmental obesogen tributyltin chloride acts via peroxisome proliferator activated receptor gamma to induce adipogenesis in murine 3t3-l1 preadipocytes. J Steroid Biochem Mol Biol 127, 9-15.
85. Lillycrop KA. (2011) Effect of maternal diet on the epigenome: implications for human metabolic disease. Proc Nutr Soc 70, 64-72.
86. Lillycrop KA & Burdge GC. (2011) Epigenetic changes in early life and future risk of obesity. Int J Obes (Lond) 35, 72-83.
87. Lillycrop KA, Phillips ES, Torrens C, Hanson MA, Jackson AA & Burdge GC. (2008) Feeding pregnant rats a protein-restricted diet persistently alters the methylation of specific cytosines in the hepatic ppar alpha promoter of the offspring. Br J Nutr 100, 278-282.
88. Livingstone DE, Jones GC, Smith K, Jamieson PM, Andrew R, Kenyon CJ & Walker BR. (2000) Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese zucker rats. Endocrinology 141, 560-563.
89. Lu M, Sarruf DA, Talukdar S, Sharma S, Li P, Bandyopadhyay G et al. (2011) Brain ppar-gamma promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones. Nat Med 17, 618-622.
90. Lustig RH. (2006) Childhood obesity: behavioral aberration or biochemical drive? Reinterpreting the first law of thermodynamics. Nat Clin Pract Endocrinol Metab 2, 447-458.
91. Lustig RH. (2010) Fructose: metabolic, hedonic, and societal parallels with ethanol. J Am Diet Assoc 110, 1307-1321.
92. Maffei L, Rochira V, Zirilli L, Antunez P, Aranda C, Fabre B et al. (2007) A novel compound heterozygous mutation of the aromatase gene in an adult man: reinforced evidence on the relationship between congenital oestrogen deficiency, adiposity and the metabolic syndrome. Clin Endocrinol (Oxf) 67, 218-224.
93. le Maire A, Grimaldi M, Roecklin D, Dagnino S, Vivat-Hannah V, Balaguer P & Bourguet W. (2009) Activation of rxr-ppar heterodimers by organotin environmental endocrine disruptors. EMBO Rep 10, 367-373.
94. Maloney EK & Waxman DJ. (1999) Trans-activation of pparalpha and ppargamma by structurally diverse environmental chemicals. Toxicol Appl Pharmacol 161, 209-218.
95. Marin P, Darin N, Amemiya T, Andersson B, Jern S & Bjorntorp P. (1992) Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism 41, 882-886.
96. Mendez MA, Garcia-Esteban R, Guxens M, Vrijheid M, Kogevinas M, Goni F, Fochs S & Sunyer J. (2011) Prenatal organochlorine compound exposure, rapid weight gain, and overweight in infancy. Environ Health Perspect 119, 272-278.
97. Muhlhausler B & Smith SR. (2009) Early-life origins of metabolic dysfunction: role of the adipocyte. Trends Endocrinol Metab 20, 51-57.
98. Myers MG Jr & Burant CF. (2011) Ppar-gamma action: it's all in your head. Nat Med 17, 544-545.
99. Nath M. (2008) Toxicity and the cardiovascular activity of organotin compounds: a review. Appl Organomet Chem 22, 598-612.
100. Nemeroff CB. (1997) Dosing the antipsychotic medication olanzapine. J Clin Psychiatry 58(Suppl. 10), 45-49.
101. Newbold RR. (2010) Impact of environmental endocrine disrupting chemicals on the development of obesity. Hormones (Athens) 9, 206-217.
102. Newbold RR. (2011) Perinatal exposure to endocrine disrupting chemicals with estrogenic activity and the development of obesity. In: Obesity Before Birth, Vol. 30. (ed. RH Lustig ), pp. 367-382. Springer, US.
103. Newbold RR, Padilla-Banks E, Snyder RJ & Jefferson WN. (2005) Developmental exposure to estrogenic compounds and obesity. Birth Defects Res A Clin Mol Teratol 73, 478-480.
104. Newbold RR, Padilla-Banks E, Jefferson WN & Heindel JJ. (2008) Effects of endocrine disruptors on obesity. Int J Androl 31, 201-208.
105. Newbold RR, Padilla-Banks E & Jefferson WN. (2009) Environmental estrogens and obesity. Mol Cell Endocrinol 304, 84-89.
106. Nolte RT, Wisely GB, Westin S, Cobb JE, Lambert MH, Kurokawa R, Rosenfeld MG, Willson TM, Glass CK & Milburn MV. (1998) Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature 395, 137-143.
107. Odermatt A & Gumy C. (2008) Glucocorticoid and mineralocorticoid action: why should we consider influences by environmental chemicals? Biochem Pharmacol 76, 1184-1193.
108. Oken E, Huh SY, Taveras EM, Rich-Edwards JW & Gillman MW. (2005) Associations of maternal prenatal smoking with child adiposity and blood pressure. Obes Res 13, 2021-2028.
109. Ong KK & Dunger DB. (2002) Perinatal growth failure: the road to obesity, insulin resistance and cardiovascular disease in adults. Best Pract Res Clin Endocrinol Metab 16, 191-207.
110. Ong KK, Ahmed ML, Emmett PM, Preece MA & Dunger DB. (2000) Association between postnatal catch-up growth and obesity in childhood: prospective cohort study. BMJ 320, 967-971.
111. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S & Marshak DR. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147.
112. Piver WT. (1973) Organotin compounds: industrial applications and biological investigation. Environ Health Perspect 4, 61-79.
113. Power C & Jefferis BJ. (2002) Fetal environment and subsequent obesity: a study of maternal smoking. Int J Epidemiol 31, 413-419.
114. Rask E, Olsson T, Soderberg S, Andrew R, Livingstone DE, Johnson O & Walker BR. (2001) Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 86, 1418-1421.
115. Rubenstrunk A, Hanf R, Hum DW, Fruchart JC & Staels B. (2007) Safety issues and prospects for future generations of ppar modulators. Biochim Biophys Acta 1771, 1065-1081.
116. Rubin BS. (2011) Bisphenol a: an endocrine disruptor with widespread exposure and multiple effects. J Steroid Biochem Mol Biol 127, 27-34.
117. Rubin BS & Soto AM. (2009) Bisphenol a: perinatal exposure and body weight. Mol Cell Endocrinol 304, 55-62.
118. Rubin BS, Murray MK, Damassa DA, King JC & Soto AM. (2001) Perinatal exposure to low doses of bisphenol a affects body weight, patterns of estrous cyclicity, and plasma lh levels. Environ Health Perspect 109, 675-680.
119. Ryan KK, Haller AM, Sorrell JE, Woods SC, Jandacek RJ & Seeley RJ. (2010) Perinatal exposure to bisphenol-a and the development of metabolic syndrome in cd-1 mice. Endocrinology 151, 2603-2612.
120. Ryan KK, Li B, Grayson BE, Matter EK, Woods SC & Seeley RJ. (2011) A role for central nervous system ppar-gamma in the regulation of energy balance. Nat Med 17, 623-626.
121. Schlumbohm C, Bramlage C, Strutz F, Armstrong VW, Oellerich M & Fuchs E. (2007) Predictive value of maternal bodyweight, postnatal weight gain and prenatal dexamethasone overexposure for the development of obesity in adult marmoset monkeys. Exp Clin Endocrinol Diabetes 115, 8.
122. Seckl JR. (2001) Glucocorticoid programming of the fetus; adult phenotypes and molecular mechanisms. Mol Cell Endocrinol 185, 61-71.
123. Seckl JR, Morton NM, Chapman KE & Walker BR. (2004) Glucocorticoids and 11beta-hydroxysteroid dehydrogenase in adipose tissue. Recent Prog Horm Res 59, 359-393.
124. Sergeev AV & Carpenter DO. (2010) Increased hospitalizations for ischemic stroke with comorbid diabetes and residential proximity to sources of organic pollutants: a 12-year population-based study. Neuroepidemiology 35, 196-201.
125. Sergeev AV & Carpenter DO. (2011) Increase in metabolic syndrome-related hospitalizations in relation to environmental sources of persistent organic pollutants. Int J Environ Res Public Health 8, 762-776.
126. Shimasaki Y, Kitano T, Oshima Y, Inoue S, Imada N & Honjo T. (2003) Tributyltin causes masculinization in fish. Environ Toxicol Chem 22, 141-144.
127. Shukla SJ, Huang R, Austin CP & Xia M. (2010) The future of toxicity testing: a focus on in vitro methods using a quantitative high-throughput screening platform. Drug Discov Today 15, 997-1007.
128. Skinner MK. (2010) Metabolic disorders: fathers' nutritional legacy. Nature 467, 922-923.
129. Skinner MK, Manikkam M & Guerrero-Bosagna C. (2011) Epigenetic transgenerational actions of endocrine disruptors. Reprod Toxicol 31, 337-343.
130. Stahlhut RW, van Wijgaarden E, Dye TD, Cook S & Swan SH. (2007) Concentrations of urinary phthalate metabolites are associated with increased waist circumferece and insulin resistance in adult U.S. Males. Environ Health Perspect 115, 876-882.
131. van Straten EME, Bloks VW, Huijkman NCA, Baller JFW, Meer Hv, Lutjohann D, Kuipers F & Plosch T. (2010) The liver x-receptor gene promoter is hypermethylated in a mouse model of prenatal protein restriction. Am J Physiol Regul Integr Comp Physiol 298, R275-R282.
132. Tang-Peronard JL, Andersen HR, Jensen TK & Heitmann BL. (2011) Endocrine-disrupting chemicals and obesity development in humans: a review. Obes Rev 12, 622-636.
133. Tontonoz P & Spiegelman BM. (2008) Fat and beyond: the diverse biology of ppargamma. Annu Rev Biochem 77, 289-312.
134. Valsamakis G, Anwar A, Tomlinson JW, Shackleton CH, McTernan PG, Chetty R et al. (2004) 11beta-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus. J Clin Endocrinol Metab 89, 4755-4761.
135. Vandenberg LN, Maffini MV, Sonnenschein C, Rubin BS & Soto AM. (2009) Bisphenol-a and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev 30, 75-95.
136. Wade GN, Gray JM & Bartness TJ. (1985) Gonadal influences on adiposity. Int J Obes 9(Suppl. 1), 83-92.
137. Wake DJ, Rask E, Livingstone DE, Soderberg S, Olsson T & Walker BR. (2003) Local and systemic impact of transcriptional up-regulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity. J Clin Endocrinol Metab 88, 3983-3988.
138. Weinstock M. (2005) The potential influence of maternal stress hormones on development and mental health of the offspring. Brain Behav Immun 19, 296-308.
139. Welberg LA, Seckl JR & Holmes MC. (2000) Inhibition of 11beta-hydroxysteroid dehydrogenase, the foeto-placental barrier to maternal glucocorticoids, permanently programs amygdala gr mrna expression and anxiety-like behaviour in the offspring. Eur J Neurosci 12, 1047-1054.
140. Wu Q, Ohsako S, Ishimura R, Suzuki JS & Tohyama C. (2004) Exposure of mouse preimplantation embryos to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (tcdd) alters the methylation status of imprinted genes h19 and igf2. Biol Reprod 70, 1790-1797.
141. Wu Q, Zhou ZJ & Ohsako S. (2006) [effect of environmental contaminants on DNA methyltransferase activity of mouse preimplantation embryos]. Wei Sheng Yan Jiu 35, 30-32.